Irritable Bowel Syndrome (IBS) is one of the most underestimated, widespread disorders in industrialized countries. IBS patients suffer from diverse symptoms such as constipation, diarrhoea, abdominal pain, flatulence, and bloating. In addition, IBS can significantly impair patients’ quality of life.
After a long research process, scientists finally found one unique bacteria strain that has been shown to significantly relieve IBS and its symptoms and to simultaneously improve IBS patients’ quality of life. This unique and patented bifidobacteria strain B. bifidum MIMBb75 is only available in Kijimea IBS, a medical device for the treatment of IBS.
Experts are increasingly convinced that IBS may be caused by small damages in the intestinal barrier. These allow pollutants and pathogens to enter the intestinal wall and to trigger the typical IBS symptoms. The unique bifidobacterium contained in Kijimea IBS attaches itself directly to the surface of the intestinal wall and forms a protective layer. Our experts refer to this as the 'plaster effect'.
In a clinical study, Kijimea IBS has shown to significantly reduce IBS symptoms such as digestive disorder, abdominal pain and discomfort, abdominal distension and bloating. In addition, Kijimea IBS simultaneously improved the quality of life of IBS patients by a significant margin.
In other countries, Kijimea IBS has already been very well received among IBS patients. Now, this promising relief for IBS is finally available in the UK, too. To everyone suffering from IBS: This product may help you to leave your everyday worries behind!
So far, no side effects or interactions with other products have been observed in conjunction with the use of Kijimea IBS. Kijimea IBS contains neither preservatives, sweeteners, flavourings, lactose nor gluten. In addition, Kijimea IBS is suitable for a vegan diet.
Take 2 capsules once a day at mealtime. Swallow capsules whole with a sufficient amount of fluid (e.g. a glass of water).
In order to achieve the best results, Kijimea IBS capsules should be taken for at least four weeks, ideally for twelve weeks. In a clinical study, the first positive effects have been seen after about one week of regular ingestion.
Kijimea IBS has no known side effects and no known drug interactions. In the event of new or longer-lasting symptoms you should consult a doctor so that the cause of the symptoms and any potential underlying illness requiring treatment can be diagnosed. Keep out of reach of children. Do not use Kijimea IBS capsules after the expiry date printed on the packaging.
These capsules contain the unique bifidobacteria strain B bifidum MIMBb75. Other ingredients are: maize starch, hypromellose, magnesium stearate, silicium dioxide, titanium dioxide, iron oxide and Brilliant Blue FCF.
The views expressed are those of our customers. If you require advice on a condition or treatment, please contact your doctor or pharmacist. For any questions regarding the products, please contact us. Please note: due to advertising regulations, not all product reviews can be displayed. Please be advised that people respond to products differently and you should always read the label.